- Founded
- 2016
- Employees
- 30
- Total Funding
- $92M
Founded by Sung Joo LEE, Yong Sung KIM in 2016.
About Orum Therapeutics
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.
Leadership at Orum Therapeutics
The team at the top of the org chart.
SJ Lee
CEO
28 reports
Olaf Christensen
Chief Medical Officer
4 reports
Susan B.
Vice President Global Human Resources
2 reports
Maysoun Shomali
Executive Director
7 reports
Greg Dwyer
Svp, Head Of Business Development
2 reports
Chad May
Chief Scientific Officer
6 reports
Dorin Toader
SVP, Head of Platform
Christine O’Day
Senior Director, Intellectual Property
Tim Sungbeom Hong
Head of FP&A
Open Jobs at Orum Therapeutics (8)
- Orum Therapeutics · Daejeon, Korea · 2hFull-time
- Orum Therapeutics · Daejeon, Korea · 2hFull-time
- Orum Therapeutics · Lexington, Massachusetts · 2hFull-time
- Orum Therapeutics · Daejeon, Korea · 2hFull-time
- Orum Therapeutics · Lexington, Massachusetts · 2hFull-time
- Orum Therapeutics · Daejeon, Korea · 2hFull-time
- Orum Therapeutics · Shangahai, District · 2hFull-time
- Orum Therapeutics · Lexington, Massachusetts · 2hFull-time
Similar companies hiring
Top employers in Health Care